Cargando…
The Use of Microbial Accessible and Fermentable Carbohydrates and/or Butyrate as Supportive Treatment for Patients With Coronavirus SARS-CoV-2 Infection
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290455/ https://www.ncbi.nlm.nih.gov/pubmed/32582742 http://dx.doi.org/10.3389/fmed.2020.00292 |
| _version_ | 1783545679924166656 |
|---|---|
| author | Archer, Douglas L. Kramer, Dean C. |
| author_facet | Archer, Douglas L. Kramer, Dean C. |
| author_sort | Archer, Douglas L. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7290455 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-72904552020-06-23 The Use of Microbial Accessible and Fermentable Carbohydrates and/or Butyrate as Supportive Treatment for Patients With Coronavirus SARS-CoV-2 Infection Archer, Douglas L. Kramer, Dean C. Front Med (Lausanne) Medicine Frontiers Media S.A. 2020-06-05 /pmc/articles/PMC7290455/ /pubmed/32582742 http://dx.doi.org/10.3389/fmed.2020.00292 Text en Copyright © 2020 Archer and Kramer. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Medicine Archer, Douglas L. Kramer, Dean C. The Use of Microbial Accessible and Fermentable Carbohydrates and/or Butyrate as Supportive Treatment for Patients With Coronavirus SARS-CoV-2 Infection |
| title | The Use of Microbial Accessible and Fermentable Carbohydrates and/or Butyrate as Supportive Treatment for Patients With Coronavirus SARS-CoV-2 Infection |
| title_full | The Use of Microbial Accessible and Fermentable Carbohydrates and/or Butyrate as Supportive Treatment for Patients With Coronavirus SARS-CoV-2 Infection |
| title_fullStr | The Use of Microbial Accessible and Fermentable Carbohydrates and/or Butyrate as Supportive Treatment for Patients With Coronavirus SARS-CoV-2 Infection |
| title_full_unstemmed | The Use of Microbial Accessible and Fermentable Carbohydrates and/or Butyrate as Supportive Treatment for Patients With Coronavirus SARS-CoV-2 Infection |
| title_short | The Use of Microbial Accessible and Fermentable Carbohydrates and/or Butyrate as Supportive Treatment for Patients With Coronavirus SARS-CoV-2 Infection |
| title_sort | use of microbial accessible and fermentable carbohydrates and/or butyrate as supportive treatment for patients with coronavirus sars-cov-2 infection |
| topic | Medicine |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290455/ https://www.ncbi.nlm.nih.gov/pubmed/32582742 http://dx.doi.org/10.3389/fmed.2020.00292 |
| work_keys_str_mv | AT archerdouglasl theuseofmicrobialaccessibleandfermentablecarbohydratesandorbutyrateassupportivetreatmentforpatientswithcoronavirussarscov2infection AT kramerdeanc theuseofmicrobialaccessibleandfermentablecarbohydratesandorbutyrateassupportivetreatmentforpatientswithcoronavirussarscov2infection AT archerdouglasl useofmicrobialaccessibleandfermentablecarbohydratesandorbutyrateassupportivetreatmentforpatientswithcoronavirussarscov2infection AT kramerdeanc useofmicrobialaccessibleandfermentablecarbohydratesandorbutyrateassupportivetreatmentforpatientswithcoronavirussarscov2infection |